{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:02:30Z","timestamp":1790787750107,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003483","name":"Hebrew University of Jerusalem","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003483","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s40263-024-01064-5","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T17:34:32Z","timestamp":1706204072000},"page":"153-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trends in Pregabalin Use and Prescribing Patterns in the Adult Population: A 10-Year Pharmacoepidemiologic Study"],"prefix":"10.1007","volume":"38","author":[{"given":"Nofar","family":"Benassayag Kaduri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6015-9618","authenticated-orcid":false,"given":"Reuven","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiessam","family":"Abu Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4365-4528","authenticated-orcid":false,"given":"Victoria","family":"Rotshild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2018.04.025","volume":"189","author":"A Sason","year":"2018","unstructured":"Sason A, Adelson M, Schreiber S, Peles E. Pregabalin misuse in methadone maintenance treatment patients in Israel: prevalence and risk factors. Drug Alcohol Depend. 2018;189:8\u201311. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.025.","journal-title":"Drug Alcohol Depend"},{"key":"1064_CR2","unstructured":"The European Public Assessment Report (EPAR) for Lyrica. European Medicines Agency (EMA); n.d. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lyrica. Accessed 23 Dec 2023."},{"key":"1064_CR3","unstructured":"Lyrica: prescribing information. The Israeli Drug Registry, Ministry of Health; n.d. https:\/\/israeldrugs.health.gov.il\/#!\/medDetails\/132. Accessed 22 Dec 2023."},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/bjgpopen20X101120","volume":"5","author":"AL Schaffer","year":"2021","unstructured":"Schaffer AL, Busingye D, Chidwick K, Brett J, Blogg S. Pregabalin prescribing patterns in Australian general practice, 2012\u20132018: a cross-sectional study. BJGP Open. 2021;5:1\u201310. https:\/\/doi.org\/10.3399\/bjgpopen20X101120.","journal-title":"BJGP Open"},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/JAMAINTERNMED.2017.7856","volume":"178","author":"ME Johansen","year":"2018","unstructured":"Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Intern Med. 2018;178:292\u20134. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2017.7856.","journal-title":"JAMA Intern Med"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/J.BJA.2020.05.017","volume":"125","author":"N Torrance","year":"2020","unstructured":"Torrance N, Veluchamy A, Zhou Y, Fletcher EH, Moir E, Hebert HL, et al. Trends in gabapentinoid prescribing, co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. Br J Anaesth. 2020;125:159\u201367. https:\/\/doi.org\/10.1016\/J.BJA.2020.05.017.","journal-title":"Br J Anaesth"},{"key":"1064_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMP1704633\/SUPPL_FILE\/NEJMP1704633_DISCLOSURES.PDF","volume":"377","author":"CW Goodman","year":"2017","unstructured":"Goodman CW, Brett AS. Gabapentin and pregabalin for pain\u2014is increased prescribing a cause for concern? New Engl J Med. 2017;377:411\u20134. https:\/\/doi.org\/10.1056\/NEJMP1704633\/SUPPL_FILE\/NEJMP1704633_DISCLOSURES.PDF.","journal-title":"New Engl J Med"},{"key":"1064_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/1556-4029.13263","volume":"62","author":"SP Elliott","year":"2017","unstructured":"Elliott SP, Burke T, Smith C. Determining the toxicological significance of pregabalin in fatalities. J Forensic Sci. 2017;62:169\u201373. https:\/\/doi.org\/10.1111\/1556-4029.13263.","journal-title":"J Forensic Sci"},{"key":"1064_CR9","unstructured":"Drug Enforcement Administration D o. J. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule, vol 70. 2005."},{"key":"1064_CR10","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/J.EURONEURO.2017.08.430","volume":"27","author":"U Bonnet","year":"2017","unstructured":"Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017;27:1185\u2013215. https:\/\/doi.org\/10.1016\/J.EURONEURO.2017.08.430.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1064_CR11","unstructured":"World Health organization. PREGABALIN pre-review report. Expert Committee on Drug Dependence, Thirty-ninth Meeting. 2017."},{"issue":"1","key":"1064_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/S40265-020-01432-7","volume":"81","author":"KE Evoy","year":"2020","unstructured":"Evoy KE, Sadrameli S, Contreras J, Covvey JR, Peckham AM, Morrison MD. Abuse and misuse of pregabalin and gabapentin: a systematic review update. Drugs. 2020;81(1):125\u201356. https:\/\/doi.org\/10.1007\/S40265-020-01432-7.","journal-title":"Drugs"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/S40264-020-00985-6","volume":"43","author":"S H\u00e4gg","year":"2020","unstructured":"H\u00e4gg S, J\u00f6nsson AK, Ahlner J. Current evidence on abuse and misuse of gabapentinoids. Drug Saf. 2020;43:1235. https:\/\/doi.org\/10.1007\/S40264-020-00985-6.","journal-title":"Drug Saf"},{"issue":"4","key":"1064_CR14","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/S11096-020-01217-8","volume":"43","author":"KE Evoy","year":"2021","unstructured":"Evoy KE, Covvey JR, Peckham AM, Reveles KR. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample. Int J Clin Pharm. 2021;43(4):1055\u201364. https:\/\/doi.org\/10.1007\/S11096-020-01217-8.","journal-title":"Int J Clin Pharm"},{"key":"1064_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.J5312","volume":"359","author":"LK Nahar","year":"2017","unstructured":"Nahar LK, Andrews R, Murphy KG, Paterson S. Misuse of gabapentin and pregabalin may be underestimated. BMJ. 2017;359: j5312. https:\/\/doi.org\/10.1136\/BMJ.J5312.","journal-title":"BMJ"},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/02791072.2020.1861392","volume":"53","author":"E Peles","year":"2021","unstructured":"Peles E, Sason A, Schreiber S, Adelson M. Pregabalin misuse: motives, pattern, and knowledge about its risks among patients in methadone maintenance treatment. J Psychoact Drugs. 2021;53:238\u201346. https:\/\/doi.org\/10.1080\/02791072.2020.1861392.","journal-title":"J Psychoact Drugs"},{"key":"1064_CR17","unstructured":"Clalit Research Institute. n.d. http:\/\/clalitresearch.org\/about-us\/our-data\/. Accessed 19 July 2023."},{"key":"1064_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1497-4","author":"L Eder","year":"2018","unstructured":"Eder L, Cohen AD, Feldhamer I, Greenberg-Dotan S, Batat E, Zisman D. The epidemiology of psoriatic arthritis in Israel\u2014a population-based study. Arthritis Res Ther. 2018. https:\/\/doi.org\/10.1186\/s13075-017-1497-4.","journal-title":"Arthritis Res Ther"},{"key":"1064_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14729","author":"O Gendelman","year":"2021","unstructured":"Gendelman O, Shapira R, Tiosano S, Kuntzman Y, Tsur AM, Hakimian A, et al. Utilisation of healthcare services and drug consumption in fibromyalgia: a cross-sectional analysis of the Clalit Health Service database. Int J Clin Pract. 2021. https:\/\/doi.org\/10.1111\/ijcp.14729.","journal-title":"Int J Clin Pract"},{"key":"1064_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2017.02.135","volume":"241","author":"Y Yavne","year":"2017","unstructured":"Yavne Y, Tiosano S, Watad A, Comaneshter D, Cohen AD, Amital H. Investigating the link between ischemic heart disease and Behcet\u2019s disease: a cross-sectional analysis. Int J Cardiol. 2017;241:41\u20135. https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.135.","journal-title":"Int J Cardiol"},{"key":"1064_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8032528","author":"O Marom","year":"2016","unstructured":"Marom O, Rennert G, Stein N, Landsman K, Pillar G. Characteristics and trends in hypnotics consumption in the largest health care system in Israel. Sleep Disord. 2016. https:\/\/doi.org\/10.1155\/2016\/8032528.","journal-title":"Sleep Disord"},{"key":"1064_CR22","unstructured":"Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM). n.d. https:\/\/icd10cmtool.cdc.gov\/?fy=FY2023. Accessed 10 July 2021."},{"key":"1064_CR23","unstructured":"ATC\/DDD Index 2021. n.d. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 10 July 2021."},{"key":"1064_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2307\/2283989","volume":"62","author":"Z Sidak","year":"1967","unstructured":"Sidak Z. Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc. 1967;62:626\u201333. https:\/\/doi.org\/10.2307\/2283989.","journal-title":"J Am Stat Assoc"},{"key":"1064_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278893","author":"O Shaked","year":"2022","unstructured":"Shaked O, Korn L, Shapiro Y, Koren G, Zigdon A. Socio-demographic characteristics and their relation to medical service consumption among elderly in Israel during the COVID-19 lockdown in 2020 as compared to the corresponding period in 2019. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0278893.","journal-title":"PLoS ONE"},{"key":"1064_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13584-019-0294-8","author":"N Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman N, Yoffe N, Siman-Tov M, Radomislensky I, Peleg K. Achieving ethnic equality in the Israel trauma healthcare system: the case of the elderly population. Isr J Health Policy Res. 2019. https:\/\/doi.org\/10.1186\/s13584-019-0294-8.","journal-title":"Isr J Health Policy Res"},{"key":"1064_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021535","author":"A Viniol","year":"2019","unstructured":"Viniol A, Ploner T, Hickstein L, Haasenritter J, Klein KM, Walker J, et al. Prescribing practice of pregabalin\/gabapentin in pain therapy: an evaluation of German claim data. BMJ Open. 2019. https:\/\/doi.org\/10.1136\/bmjopen-2018-021535.","journal-title":"BMJ Open"},{"key":"1064_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100579","author":"J Ashworth","year":"2023","unstructured":"Ashworth J, Bajpai R, Muller S, Bailey J, Helliwell T, Harrisson SA, et al. Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study. Lancet Reg Health Eur. 2023;27:100579. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100579.","journal-title":"Lancet Reg Health"},{"key":"1064_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060104","author":"R Flemming","year":"2022","unstructured":"Flemming R. Patterns of pregabalin prescribing in four German federal states: analysis of routine data to investigate potential misuse of pregabalin. BMJ Open. 2022. https:\/\/doi.org\/10.1136\/bmjopen-2021-060104.","journal-title":"BMJ Open"},{"key":"1064_CR30","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1001\/jama.2018.12358","volume":"320","author":"F Montastruc","year":"2018","unstructured":"Montastruc F, Loo SY, Renoux C. Trends in first gabapentin and pregabalin prescriptions in primary care in the United Kingdom, 1993\u20132017. New Engl J Med. 2018;320:2149\u201351. https:\/\/doi.org\/10.1001\/jama.2018.12358.","journal-title":"New Engl J Med"},{"key":"1064_CR31","doi-asserted-by":"publisher","DOI":"10.17226\/24781","volume-title":"Pain Management and the opioid epidemic","year":"2017","unstructured":"Bonnie RJ, Ford MA, Phillips JK, editors. Pain Management and the opioid epidemic. Washington, DC: National Academies Press; 2017. https:\/\/doi.org\/10.17226\/24781."},{"key":"1064_CR32","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1213\/ANE.0000000000001404","volume":"123","author":"MC Grant","year":"2016","unstructured":"Grant MC, Betz M, Hulse M, Zorrilla-Vaca A, Hobson D, Wick E, et al. The effect of preoperative pregabalin on postoperative nausea and vomiting: a meta-analysis. Anesth Analg. 2016;123:1100\u20137. https:\/\/doi.org\/10.1213\/ANE.0000000000001404.","journal-title":"Anesth Analg"},{"key":"1064_CR33","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/bja\/aer027","volume":"106","author":"J Zhang","year":"2011","unstructured":"Zhang J, Ho KY, Wang Y. Efficacy of pregabalin in acute postoperative pain: a meta-analysis. Br J Anaesth. 2011;106:454\u201362. https:\/\/doi.org\/10.1093\/bja\/aer027.","journal-title":"Br J Anaesth"},{"issue":"5","key":"1064_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/rapm-2020-101924","volume":"46","author":"O Miron","year":"2021","unstructured":"Miron O, Zeltzer D, Shir T, Balicer RD, Einav L, Feldman BS. Rising opioid prescription fulfillment among non-cancer and non-elderly patients-Israel's alarming example. Reg Anesth Pain Med. 2021;46(5):455\u20136. https:\/\/doi.org\/10.1136\/rapm-2020-101924.","journal-title":"Reg Anesth Pain Med"},{"key":"1064_CR35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","volume":"17","author":"RA Swarm","year":"2019","unstructured":"Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, et al. Adult cancer pain, version 3.2019. JNCCN J Natl Compr Cancer Netw. 2019;17:977\u20131007. https:\/\/doi.org\/10.6004\/jnccn.2019.0038.","journal-title":"JNCCN J Natl Compr Cancer Netw"},{"key":"1064_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081992","author":"M Shkodra","year":"2022","unstructured":"Shkodra M, Caraceni A. Treatment of neuropathic pain directly due to cancer: an update. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14081992.","journal-title":"Cancers (Basel)"},{"key":"1064_CR37","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/ADD.14412","volume":"114","author":"R Cairns","year":"2019","unstructured":"Cairns R, Schaffer AL, Ryan N, Pearson SA, Buckley NA. Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings. Addiction. 2019;114:1026\u201334. https:\/\/doi.org\/10.1111\/ADD.14412.","journal-title":"Addiction"},{"key":"1064_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00228-013-1594-5","volume":"70","author":"R Bod\u00e9n","year":"2014","unstructured":"Bod\u00e9n R, Wettermark B, Brandt L, Kieler H. Factors associated with pregabalin dispensing at higher than the approved maximum dose. Eur J Clin Pharmacol. 2014;70:197\u2013204. https:\/\/doi.org\/10.1007\/s00228-013-1594-5.","journal-title":"Eur J Clin Pharmacol"},{"key":"1064_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.01022","author":"M Lancia","year":"2020","unstructured":"Lancia M, Gambelunghe A, Gili A, Bacci M, Aroni K, Gambelunghe C. Pregabalin abuse in combination with other drugs: monitoring among methadone patients. Front Psychiatry. 2020. https:\/\/doi.org\/10.3389\/fpsyt.2019.01022.","journal-title":"Front Psychiatry"},{"key":"1064_CR40","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40263-017-0467-3","volume":"31","author":"BJ Snellgrove","year":"2017","unstructured":"Snellgrove BJ, Steinert T, Jaeger S. Pregabalin use among users of illicit drugs: a cross-sectional survey in southern Germany. CNS Drugs. 2017;31:891\u20138. https:\/\/doi.org\/10.1007\/s40263-017-0467-3.","journal-title":"CNS Drugs"},{"key":"1064_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amepre.2021.08.024","volume":"62","author":"C Chen","year":"2022","unstructured":"Chen C, Lo-Ciganic WH, Winterstein AG, Tighe P, Wei YJJ. Concurrent use of prescription opioids and gabapentinoids in older adults. Am J Prev Med. 2022;62:519\u201328. https:\/\/doi.org\/10.1016\/j.amepre.2021.08.024.","journal-title":"Am J Prev Med"},{"key":"1064_CR42","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s11096-020-01217-8","volume":"43","author":"KE Evoy","year":"2021","unstructured":"Evoy KE, Covvey JR, Peckham AM, Reveles KR. Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample. Int J Clin Pharm. 2021;43:1055\u201364. https:\/\/doi.org\/10.1007\/s11096-020-01217-8.","journal-title":"Int J Clin Pharm"},{"key":"1064_CR43","unstructured":"Manor O, Abu Ahmad W, Ben-Yehuda A, Horwitz E, Wolff-Sagy Y, Paltiel O, et al. The 2011\u20132015 National Program for Quality Indicators in Community Healthcare in Israel (QICH) Report. https:\/\/israelhealthindicators.org."},{"key":"1064_CR44","unstructured":"Calderon-Margalit, Abu-Ahmed W, Ben-Yehuda A, Horwitz E, Krieger M, Manor O, et al. The 2015\u20132017 National Program for Quality Indicators in Community Healthcare in Israel (QICH) Report. https:\/\/israelhealthindicators.org."},{"key":"1064_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1080\/13607863.2011.644262","volume":"16","author":"T Blumstein","year":"2012","unstructured":"Blumstein T, Benyamini Y, Chetrit A, Mizrahi EH, Lerner-Geva L. Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart. Aging Ment Health. 2012;16:636\u201347. https:\/\/doi.org\/10.1080\/13607863.2011.644262.","journal-title":"Aging Ment Health"},{"key":"1064_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10488-011-0381-9","volume":"40","author":"L Ayalon","year":"2013","unstructured":"Ayalon L, Gross R, Yaari A, Feldhamer E, Balicer RD, Goldfracht M. Patients\u2019 and physicians\u2019 characteristics associated with the purchase of benzodiazepines by older primary care patients in Israel. Adm Policy Ment Health Ment Health Serv Res. 2013;40:117\u201323. https:\/\/doi.org\/10.1007\/s10488-011-0381-9.","journal-title":"Adm Policy Ment Health Ment Health Serv Res"},{"key":"1064_CR47","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.5268","author":"ED Peet","year":"2022","unstructured":"Peet ED, Dana B, Sheng FY, Powell D, Shetty K, Stein BD. Trends in the concurrent prescription of opioids and gabapentin in the US, 2006 to 2018. JAMA Intern Med. 2022. https:\/\/doi.org\/10.1001\/jamainternmed.2022.5268.","journal-title":"JAMA Intern Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01064-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-024-01064-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-024-01064-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:07:50Z","timestamp":1723032470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-024-01064-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s40263-024-01064-5","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"10 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Hebrew University of Jerusalem. The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no relevant conflicts of interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data supporting the findings of this study are accessible from the corresponding author upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approved by the institutional review board of Clalit Health Services (CHS). The ethic approval number is 0153-21-COM2.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors received a full exemption from informed consent because this study consists of existing data and given that anonymized data were used.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed to the study conception and design. WAA conducted the statistical analyses with guidance from VR and NBK. The first draft of the manuscript was written by NBK. All authors contributed significantly to draft refinement and data interpretation. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}